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The S100 proteins comprise a family of 21 low molecular weight (9–13 kDa) proteins that are characterized by the
presence of two calcium-binding EF-hand motifs. Fourteen S100 protein genes are located within the epidermal
differentiation complex on human chromosome 1q21 and 13 S100 proteins (S100A2, S100A3, S100A4, S100A6,
S100A7, S100A8, S100A9, S100A10, S100A11, S100A12, S100A15, S100B, and S100P) are expressed in normal and/
or diseased epidermis. S100 proteins exist in cells as anti-parallel hetero- and homodimers and upon calcium
binding interact with target proteins to regulate cell function. S100 proteins are of interest as mediators of calcium-
associated signal transduction and undergo changes in subcellular distribution in response to extracellular
stimuli. They also function as chemotactic agents and may play a role in the pathogenesis of epidermal disease, as
selected S100 proteins are markedly overexpressed in psoriasis, wound healing, skin cancer, inﬂammation, cellular
stress, and other epidermal states.
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S100 Proteins
The S100 proteins comprise a multigene family of low
molecular weight proteins that engage in multiple functions
in a wide variety of cell types and tissues (Heizmann et al,
2002; Donato, 2003). Many members of this family of gene
are encoded in the epidermal differentiation complex (EDC)
located on chromosome 1q21 (Volz et al, 1993; Hardas et al,
1996; Wicki et al, 1996). This region is of particular interest,
since it encodes many genes (involucrin, filaggrin, trichoya-
lin, repetin, etc.) that are expressed in epidermal keratino-
cytes (Mischke et al, 1996; South et al, 1999). Thus, the
finding that many S100 genes are clustered within the EDC
has heightened interest in their role in the epidermis. Among
the 21 S100 proteins that have been cloned to date, 11, in-
cluding S100A2, S100A3, S100A4, S100A6, S100A7, S100A8,
S100A9, S100A10, S100A11, S100A12, and S100A15, are
expressed in the human epidermis or in cultured keratino-
cytes (Boni et al, 1997; Xia et al, 1997; Broome et al, 2003;
Wolf et al, 2003). In addition, S100B is expressed in Lang-
erhans cells and melanocytes (Boni et al, 1997; Shrestha
et al, 1998; Park and Min, 2003) and S100P is expressed
in Meissner’s corpuscles (Del Valle et al, 1994) (Table I).
It is thought that S100 proteins serve as calcium sensor
proteins that, upon activation, regulate the function and/or
subcellular distribution of specific target proteins (Donato,
1999). S100 proteins are characterized by common struc-
tural motifs including two EF hands (helix-loop-helix
calcium-binding domains) that are separated by a hinge
region and flanked by amino- and carboxy-terminal
domains (Fig 1A). The canonical C-terminal EF-hand binds
calcium with a 100-fold higher affinity than the N-terminal,
non-conventional, EF-hand (Gribenko and Makhatadze,
1998; Zimmer et al, 2003). The carboxy-terminal domain is
variable among S100 proteins and is thought to provide the
site responsible for the selective interaction of each
individual S100 protein with specific target proteins (Kube
et al, 1992; Seemann et al, 1996). Figure 1B shows the
amino acid sequence of the S100 proteins known to be
expressed in the epidermis. This alignment reveals the
EF-hands, the hinge region, the a-helical domains, and the
N- and C-terminal extensions.
S100 proteins exist in cells as anti-parallel homo- and
heterodimers in which the monomers are held together by
non-covalent interactions and are oriented by a 2-fold axis
of rotation (Brodersen et al, 1998; Sastry et al, 1998;
Ishikawa et al, 2000; Moroz et al, 2000) (Fig 1C). Helices I
and IV, which flank the calcium-binding EF-hands, come
together to form the dimer interface (Drohat et al, 1997,
1998). S100B, for example, exists as a non-covalent dimer
in the presence or absence of calcium, suggesting that
calcium is not required for dimer formation (Drohat et al,
1997). Thus, S100 proteins are likely to exist in cells as pre-
assembled dimers (Zimmer et al, 2003). Upon calcium
binding, the helices rearrange and a cleft forms in each
monomer. The residues present in this cleft create a target
protein recognition site (Brodersen et al, 1998; Sastry et al,
1998; Rety et al, 1999; Moroz et al, 2000; Rety et al, 2000;
Donato, 2001; McClintock and Shaw, 2003). Because of the
anti-parallel structure of the S100 dimer, target protein
Abbreviations: E-FABP, epidermal fatty acid binding protein; RAGE,
receptor for advanced glycation endproducts
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monomers can bind on opposite ends of the S100 protein
dimer. Thus, the S100 protein dimer is, in effect, a cross-
bridge between the two target proteins (Fig 1C), and the
ultimate complex is a heterotetramer composed of two
S100 protein subunits and two target protein subunits. A
calcium-dependent S100 protein conformation change is
required for interaction with target proteins, a topic that is
covered in depth in two recent reviews (Nelson and Chazin,
1998; Zimmer et al, 2003). There is presently, however, no
direct evidence that calcium causes a change in S100
protein conformation in the intracellular environment. In
fact, it can be argued that the affinity of the EF-hands for
calcium (1–100 mM) (Baudier et al, 1986; Kligman and Hilt,
1988; Gribenko and Makhatadze, 1998; Rustandi et al,
1998) is below the level required for calcium sensitivity in the
intracellular keratinocyte environment where calcium levels
are approximately 100 nM (Hennings et al, 1989). Calcium-
binding affinity for S100 proteins, however, is influenced by
a variety of ions and other proteins (Rustandi et al, 1998;
Zimmer et al, 2003). For example, S100B binding to a
peptide fragment derived from p53 increases the affinity of
calcium binding to S100B by 3-fold (Rustandi et al, 1998).
Thus, predicting the intracellular affinity for calcium is
difficult and it is widely believed, based on functional
evidence, that these proteins are calcium responsive in
cells. In a few cases, S100 proteins are calcium insensitive.
For example, S100A10, due to mutations in the EF-hands, is
perpetually in an ‘‘open conformational state’’ and, there-
fore, does not require calcium for activation (Gerke and
Weber, 1985; Rety et al, 1999).
The main focus of many studies in keratinocytes has
been localizing these proteins in normal and diseased
epidermis. This information is summarized in Table I.
Compared with other cell types (Heizmann and Cox, 1998;
Donato, 1999), information regarding S100 protein function
in keratinocytes is limited. Recent studies, however,
Figure 1
S100 protein structure. (A) The overall structure of each S100 protein family member includes four a-helical segments, two calcium-binding EF-
hands (one non-canonical site binds calcium with low affinity, and one canonical), a central hinge region of variable length, and the C- and N-terminal
variable domains. (B) The amino acid sequences of the human S100 proteins expressed in epidermis are aligned with the EF-hands and central
hinge region indicated. All sequences are human and the accession numbers are S100A2, NM_005978; S100A3, BC012893; S100A4, NM_019554;
S100A6, BC001431; S100A7, BC034687; S100A8, BC005928; S100A9, BC047681; S100A10, XM_001468; S100A11, X80201; S100A12,
NM_005621; S100A15, AY189119; S100B NM_006272. The ClustalW sequence comparison program, http://decypher.stanford.edu/index_by_algo.
shtml, was used to align the protein sequences. The alignment was then further adjusted as described by Zimmer et al (2003). (C) Model of S100
protein/target protein interaction. S100 proteins exist as anti-parallel dimers. An increase in calcium concentration results in a conformation change
in the dimer that results in exposure of a cleft, which forms the target protein binding site (cross-hatched). Once in the calcium-loaded state, each
S100 protein dimer can interact with a target protein via its C-terminal domain. Thus, a single S100 protein dimer can ligate two target proteins.
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suggest potential roles for S100 proteins in epidermal
wound repair, cancer, differentiation, and response to
stress. The following paragraphs focus on the function of
individual S100 proteins in the epidermis.
S100A2 Is an Oxidative Stress-Regulated
Protein
S100A2 (S100L) is localized to the basal layer of normal
human epidermis and hair follicles (Boni et al, 1997;
Shrestha et al, 1998). The most common form of S100A2
is overexpressed in psoriasis, although some polymorphic
S100A2 forms are not (Stoll et al, 2001). S100A2 has a
strong tendency to form homodimers as measured by
interaction in a yeast two-hybrid screen and by immuno-
precipitation (Deshpande et al, 2000). Moreover, when
exposed to oxidizing conditions, the homodimers become
linked via disulfide bonds (Deshpande et al, 2000). In
cultured normal human keratinocytes, S100A2 is found
mainly in the nucleus (Zhang et al, 2002). H2O2 treatment of
normal keratinocytes causes a relocation of S100A2 from
the nucleus to the cytoplasm. This translocation is also
observed when cells are exposed to an ionophore-
dependent increase in intracellular calcium, and both the
H2O2- and ionophore-dependent translocation is inhibited
by treatment with reducing agent. S100A2 translocation
occurs within 1 h after treatment with H2O2 and cell death
follows within 24 h. Thus, S100A2 translocation is an early
marker of oxidative stress-related keratinocyte cell death.
The inhibition of translocation from nucleus to cytoplasm by
reducing agent treatment suggests that disulfide-linked
dimer formation is required for movement (Deshpande et al,
2000). S100A2 expression is markedly increased in ErbB-
driven epidermal hyperplasia, and decreased in the ab-
sence of functional p53 in carcinoma cell lines and tumors
(Xia et al, 1997); however, the biological importance of this
S100 protein concentration change is not known.
S100A7 Is Overexpressed in Disease
S100A7, also called psoriasin, is distributed in the cyto-
plasm of keratinocytes in normal human epidermis and is
present at the cell periphery in terminally differentiated
keratinocytes (Broome et al, 2003). The peripheral distribu-
tion observed in differentiated cells may be important,
since, under some conditions, S100A7 may be released
from keratinocytes. Several S100 proteins are thought to be
secreted (Hitomi et al, 1996; Katz and Taichman, 1999;
Karimi-Busheri et al, 2002). Indeed, S100A7 has been
shown to function as a chemotactic agent and as a cytokine
(Hoffmann et al, 1994; Jinquan et al, 1996), and to attract
CD4þ lymphocytes and neutrophils (Jinquan et al, 1996).
Originally characterized as a marker of psoriasis, S100A7
overexpression is seen in many epidermal inflammatory
diseases, including atopic dermatitis, mycosis fungoides,
Darier’s disease, and inflammatory lichen sclerosus and
atrophicus (Madsen et al, 1991; Algermissen et al, 1996;
Broome et al, 2003). The high level of expression in active
psoriatic lesions has prompted investigators to suggest that
S100A7 may have a chemotactic role in psoriasis (Jinquan
et al, 1996). S100A7 expression is also increased in invasive
skin cancers such as squamous cell carcinoma, and
squamous carcinoma in situ, but not in basal cell carcinoma
(Alowami et al, 2003).
S100A7 Expression Is Regulated by
Various Agents
Topical treatment with all-trans retinoic acid results in a
rapid increase in S100A7 level in the human epidermis, as
does retinoid treatment of cultured keratinocytes (Tavakkol
et al, 1994; Zouboulis et al, 1996). Calcium also increases
keratinocyte S100A7 level (Hoffmann et al, 1994). In
addition, recent studies indicate that UV light increases
S100A7 expression in the human epidermis coincident with
increases in adhesion protein (LFA1/ICAM-1) expression (Di
Nuzzo et al, 2000). This increase in LFA-1/ICAM-1 and
S100A7 level is associated with increased epidermal
accumulation of CD4þ T cells in response to UV treatment
(Di Nuzzo et al, 2000). Taken together, these studies suggest
that S100A7 levels increase in response to inflammatory
stress and that the S100A7 protein may function as a
keratinocyte-derived chemotactic agent for immune cells
(Fig 2A). Indeed, this may also be the role of S1007 in
psoriasis.
S100A7 Interacts with Epidermal-Fatty Acid
Binding Protein
As previously mentioned, S100 proteins are thought to
regulate cell function by interacting with target proteins in a
calcium-dependent manner. Thus, substantial effort has
been directed to identify these target proteins in numerous
systems. But less information is available in keratinocytes.
Early studies identified epidermal fatty acid binding protein
(E-FABP) as a candidate target of S100A7. Celis and
colleagues first identified and cloned E-FABP as an over-
expressed protein in the epidermis (Madsen et al, 1992).
E-FABP is one member of a multigene family of proteins that
are required for fatty acid solubility, influx across the plasma
membrane, intracellular transport and storage, and meta-
bolism (Hertzel and Bernlohr, 2000). Siegenthaler and
colleagues confirmed that E-FABP level is elevated in
psoriasis and showed that immunoprecipitation of psoriatic
scale extracts with anti-E-FABP results in co-immuno-
precipitation of S100A7 (Hagens et al, 1999b). Additional
studies showed that nitrocellulose-immobilized E-FABP can
bind S100A7 (Hagens et al, 1999a).
A recent study that examines S100A7 and E-FABP
distribution and interaction in cultured normal human
keratinocytes (Ruse et al, 2003) confirms and extends the
observations of Siegenthaler et al (Hagens et al, 1999a, b).
In this study, S100A7 and E-FABP were overexpressed in
keratinocytes to produce a disease-like intracellular level of
S100A7. Three lines of evidence suggest a possible
functional interaction between S100A7 and E-FABP. First,
overexpression of S100A7 results in increased levels of E-
FABP and vice versa, suggesting post-translational stabili-
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zation (Ruse et al, 2003). Second, S100A7 and E-FABP co-
immunoprecipitate––this suggests that they are part of a
complex. In addition, individual E-FABP and S100A7
monomers are released after immunoprecipitation, indicat-
ing that the individual subunits of the complex are not
modified as part of the interaction (Ruse et al, 2003). Third,
S100A7 and E-FABP co-localize in resting cells in a diffuse
cytoplasmic pattern. There are not overt changes in cell
morphology in the presence of overexpressed S100A7 and/
or E-FABP.
A potentially important finding of this study is that
calcium/ionophore treatment causes movement of S100A7
and E-FABP to cell-associated peripheral structures that
protrude from the cell surface to contact the substrate.
Formation of these structures does not require S100A7 or
E-FABP; however, both proteins localize in these structures
following calcium/ionophore treatment. These structures
also contain the focal adhesion proteins, paxillin and
a-actinin, suggesting that S100A7 and E-FABP participate
in focal adhesion-related functions. These studies may be
physiologically meaningful, as immunohistological studies
suggest that S100A7 redistributes from the cytoplasm to a
cell peripheral location during keratinocyte differentiation in
the epidermis (Broome et al, 2003; Ruse et al, 2003). It
should be noted that although a change in S100A7/E-FABP
distribution is observed when cells are treated with calcium,
not all agents that regulate keratinocyte function promote
S100A7 redistribution. Like calcium, okadaic acid treatment
also causes S100A7 to move to peripheral focal adhesion-
like structures. In contrast, no change in distribution is
observed following treatment with phorbol ester, an agent
known to promote keratinocyte differentiation (Ruse et al,
2003). It is interesting to speculate regarding the function of
the S100A7/E-FABP complex. Although no specific function
has been assigned to E-FABP, both free E-FABP and the
S100A7/E-FABP complex bind oleic acid, suggesting a role
Figure 2
Possible S100 protein functions in keratino-
cytes. The plasma membrane (PM), S100 pro-
tein (S100), type I transglutaminase (TG), CD4þ
lymphocytes, annexin, and S100 target protein
(target) are indicated. The black lines in panel (D)
and (E) represent covalent transglutaminase-
mediated covalent inter-protein cross-links. All
S100 dimers are anti-parallel and S100 and
annexin are regarded as fully calcium-loaded
following application of stimulus (see text for
details).
S100 PROTEIN IN EPIDERMIS 27123 : 1 JULY 2004
in oleic acid transport and metabolism (Hagens et al,
1999a). Oleic acid may have a role in inflammation, as
topical application modulates epidermal Langerhans cells
density (Touitou et al, 2002). The complex could also
function in lipid metabolism and transport during epidermal
barrier assembly and may also modulate the inflammatory
response in psoriasis and other epidermal diseases.
S100A8 and S100A9 Are Stress-Induced
Proteins
S100A8 and S100A9 form homo- and heterodimers and are
frequently co-expressed (Teigelkamp et al, 1991). In normal
epidermis, S100A8 and S100A9 are expressed at very low
levels, although occasional expression is observed in the
granular layer. Both proteins are highly overexpressed in
psoriasis and are present in the basal, granular, and spinous
layers (Broome et al, 2003). S100A8 and S100A9 may have
a role in promoting and/or responding to the hyperproli-
ferative state in the epidermis, as S100A8 and S100A9
expression is strongly induced within the first week after
epidermal injury (Thorey et al, 2001). The increased
expression of S100A8 and S100A9 in wound-associated
keratinocytes may be related to the activated state of the
keratinocytes and not caused by the accompanying
inflammation. This idea is based on their observation that
S100A8 and S100A9 levels are increased in the epidermis of
activin-overexpressing mice that display epidermal hyper-
proliferation without inflammation. In addition, S100A8 and
S100A9 are efficiently secreted from cultured immortalized
(HaCaT) keratinocytes (Thorey et al, 2001). S100A8 and
S100A9 are also released from neutrophils via a micro-
tubule-dependent mechanism and may enhance inflamma-
tion by influencing leukocyte trafficking (Kerkhoff et al, 1999;
Kerkhoff et al, 2001). Thus, S100A8 and S100A9 release
from keratinocytes may initiate immune cell invasion that is
further propagated by the release of S100A8 and S100A9
from incoming neutrophils (Fig 2A).
A recent study showed that ultraviolet A irradiation of
mouse epidermis causes a concentration-dependent in-
crease in S100A8 level (Grimbaldeston et al, 2003).
Ultraviolet A irradiation produces an oxidizing environment
that appears to influence S100 production. For example, an
ultraviolet A-dependent increase in S100A8 expression is
observed in mouse keratinocyte PAM212 cells and this
increase is inhibited by treatment with Tempol, a superoxide
enzyme-mimicking agent, suggesting a role for oxidative
stress in the S100A8 induction (Grimbaldeston et al, 2003).
Surprisingly, the level of S100A9, the heterodimeric partner
of S100A8, did not increase along with S100A8. This
suggests that S100A8 may function as a homodimer in this
model. It is known that S100A8 homodimers can produce
different responses compared with S100A8/S100A9 hetero-
dimers (Newton and Hogg, 1998; Kerkhoff et al, 1999; Eue
et al, 2002). The observation that S100A8 levels increase
without a corresponding increase in S100A9 is interesting
and differs from recent transgenic S100A9 knockout mouse
studies showing that elimination of S100A9 results in a co-
ordinate loss of S100A8 (Manitz et al, 2003). A recent study
shows that S100A8 and S100A9 levels increase in response
to a wide variety of skin stresses, including tape stripping,
exposure to detergent, Vaseline application and UV ex-
posure (Marionnet et al, 2003). In addition, tumor promoter
treatment of mouse skin increases S100A8 and S100A9
level and glucocorticoid treatment inhibits this increase
(Gebhardt et al, 2002). These results suggest that S100A8
and S100A9 may play a role in carcinogenesis. Taken
together, these studies suggest a role for S100A8 and
S100A9 in regulating the epidermal response to tissue
injury, inflammation and disease.
S100A10, Annexin II and the Cell Periphery
S100A10 is present in both the cytoplasm and periphery in
cells of the basal and spinous layers of the human
epidermis (Broome et al, 2003). S100A10 homodimers bind
two copies of annexin II to form the calpactin I hetero-
tetramer (Nakata et al, 1990; Pigault et al, 1990). Unlike
other S100 proteins, due to a unique EF hand structure,
S100A10 is constitutively activated and binds to annexin II
in a calcium-independent manner (Gerke and Weber, 1985;
Rety et al, 1999). Calcium-activated annexin II binds to
membranes (Harder and Gerke, 1993; Ma and Ozers, 1996),
and has also been identified within the extracellular space in
keratinocytes (Ma et al, 1994; Karimi-Busheri et al, 2002).
The calpactin I complex appears to function to bring
structures together (Gerke and Moss, 2002). Because of
the propensity of annexin II to interact with and structure
membrane lipids, it is not surprising that the calpactin I
complex associates with the plasma membrane in kerati-
nocytes or that S100A10 is incorporated as a cross-linked
constituent of the keratinocyte cornified envelope (Robin-
son et al, 1997). The role of the membrane-associated
calpactin I complex in keratinocytes is not well understood;
however, it may function in remodeling the cell membrane
during keratinocyte differentiation. The S100A10 dimer
binds two annexin II target proteins, as in Fig 1C, to form
the calpactin I heterotetramer. In the presence of calcium,
the annexin II subunits of the calpactin I complex interact
with the plasma membrane (Ma and Ozers, 1996). This
interaction may function to remodel the membrane topo-
graphy (Fig 2B) in a wide range of biological contexts
including receptor internalization and endosome formation.
In addition, the ratio of S100A10 to annexin II varies during
differentiation and wound healing. S100A10 is present in all
epidermal layers, whereas annexin II is preferentially
expressed in the basal layers (Munz et al, 1997). The
functional importance of this changing ratio requires
additional study.
Like other annexin proteins, annexin II can form a
calcium channel in reconstituted systems (Gerke and Moss,
2002). Thus, in addition to its membrane structuring
function, the calpactin I complex may also form a plasma
membrane-localized calcium channel that enhances cal-
cium influx leading to calcium-dependent terminal differ-
entiation (Fig 2C). S100A10 is a transglutaminase substrate
(Ruse et al, 2001) and is found covalently incorporated into
the cornified envelope (Robinson et al, 1997). Thus, it may
have a role in cornified envelope assembly during terminal
keratinocyte differentiation (Fig 2D).
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S100A11 and Directed Movement to the
Cell Periphery
S100A11 (S100C, calgizarrin) is located in the cytoplasm of
basal epidermal keratinocytes and at the cell periphery in
spinous layer cells (Broome et al, 2003). It is also expressed
in cultured normal human keratinocytes (Broome and
Eckert, 2004). The S100A11/annexin I complex is a hetero-
tetramer consisting of two S100A11 and two annexin I
proteins. Rety et al solved the structure of this complex,
confirming a novel mode of interaction of S100A11 with
annexin I, and suggesting a model whereby the calcium-
regulated (annexin I/S100A11)2 heterotetramer could func-
tion to organize membrane fusion events (Rety et al, 2000).
Results from our laboratory indicate that S100A11 is
localized in the cytoplasm in resting cells and moves to the
cell periphery in cultured keratinocytes following calcium
challenge. This movement requires the presence of intact
microtubules (Broome and Eckert, 2004). These studies are
consistent with findings regarding S100 protein movement
and export in other cell types. For example, Rammes et al
noted that S100A8 and S100A9 are secreted independently
of the classical Golgi/ER pathway (Rammes et al, 1997).
Likewise, Roth et al demonstrated a microtubule require-
ment for S100A8/S100A9 redistribution in myelomonocytic
cells (Roth et al, 1993). S100A11 membrane association and
filament interaction has been reported by other investiga-
tors (Arcuri et al, 2002; Bianchi et al, 2003). These findings
suggest that the relocation of S100A11 to the cell periphery
that is observed during keratinocyte differentiation in vivo
(Broome et al, 2003) may be physiologically relevant, as
the (S100A11/annexin I)2 heterotetramer may function to
regulate and/or facilitate plasma membrane remodeling
during terminal differentiation (Fig 2B). The presence of
S100A10 at the cell periphery is consistent with previous
observations that S100A11 is a cross-linked component of
the cornified envelope, a structure that is assembled from
membrane-associated constituents (Robinson et al, 1997)
(Fig 2D). Moreover, annexin I is also a covalently cross-
linked cornified envelope component (Robinson et al, 1997;
Robinson and Eckert, 1998; Rety et al, 2000). S100A11 has
also been reported to be present in the nucleus in some
cultured cells and have a nuclear function (Sakaguchi et al,
2000). Indeed, some cells in human epidermal sections
show nuclear anti-S100A11 staining (Broome and Eckert,
2004). Co-localization with Langerhans cell markers, how-
ever, suggest that this nuclear staining in the epidermis is
contributed by epidermal Langerhans cells (Broome and
Eckert, 2004).
Another feature of S100A11/annexin I function may also
be important in keratinocytes. As mentioned above, almost
all annexins display calcium channel activity in in vitro
systems (Benz et al, 1996; Gerke and Moss, 2002) including
annexin I and annexin II (Chen et al, 1993; Cohen et al, 1995;
Benz et al, 1996; Burger et al, 1996). This activity has not
been demonstrated in cells under normal intracellular
conditions, but such activity may be possible under
oxidizing and reduced pH conditions (Gerke and Moss,
2002). Thus, annexin-dependent channel activity may be
possible in keratinocytes in the oxidizing, acidic environ-
ment observed during terminal keratinocyte differentiation.
The movement of S100A11 to the cell periphery during
keratinocyte differentiation in vivo (Broome et al, 2003) and
in vitro (Broome and Eckert, 2004), along with the finding
that S100A11 is a cross-linked component of the cornified
envelope (Robinson et al, 1997), suggests a differentiation-
dependent membrane-associated function. Therefore, the
(S100A11/annexin I)2 heterotetramer may have three pos-
sible roles during terminal keratinocyte differentiation. The
first is that of remodeling plasma membrane structures
during terminal differentiation. Thus interaction of annexin
with the plasma membrane lipids can join disparate
segments of membrane or bend the membrane surface
(Fig 2B). This may be important, for example, when lamellar
bodies fuse with the plasma membrane in terminally
differentiating cells. A second role is as a differentiation-
activated calcium channel that permits calcium influx in
terminally differentiating keratinocytes (Fig 2C). A gradient
of increasing free calcium is known to exist as cells move
from the basal to suprabasal layers during epidermal
differentiation (Menon et al, 1985). A mechanism may exist
whereby an increase in intracellular calcium activates
S100A11/annexin I interaction and movement to the
keratinocyte plasma membrane. Ultimately, insertion of this
complex into the plasma membrane may create a porous
environment that allows calcium to freely equilibrate be-
tween the cell interior and exterior compartments.
A third role of some S100 proteins (e.g., S100A10,
S100A11) pertains to assembly of the cornified envelope
(Fig 2D). The net result of the increased intracellular calcium
is the calcium-dependent activation of type I transglutami-
nase––the enzyme that is responsible for cornified envelope
assembly (Kim et al, 1992; Phillips et al, 1993). There is
evidence indicating that S100A11 and annexin I are cross-
linked constituents of the cornified envelope (Robinson
et al, 1997). Thus, upon completion of their physiological
function, these proteins may serve as structural compo-
nents of the skin surface. In this context, it is interesting to
note that some studies suggest that S100 proteins can be
anti-microbial (Nisapakultorn et al, 2001). Thus, the cova-
lently anchored S100 protein within the cornified envelope
may also serve a protective function.
Specific information is available regarding this cross-
linking. Type I transglutaminase is a calcium-activated,
plasma membrane-anchored protein that assembles the
covalent isopeptide cross-links that comprise the structure
of the cornified envelope (Eckert et al, 1997; Nemes and
Steinert, 1999). S100 proteins are efficient transglutaminase
substrates that are cross-linked at lysine and glutamine
residues that are located in the solvent-exposed N- and
C-terminal flanking regions of these proteins (Robinson and
Eckert, 1998; Ruse et al, 2001). The selection of these
specific residues for cross-linking is consistent with the
structure of the S100 protein dimer (i.e., a closed globular
core with exposed N- and C-termini), as cross-linking
generally is observed only in transglutaminase-accessible
regions of proteins.
Transglutaminase may also have an additional role in
regulating S100 protein/target protein interaction (Fig 2E).
Our studies indicate that the S100A11 forms antiparallel,
covalently cross-linked heterodimers in which the C-
terminus of one monomer is linked via an isopeptide bond
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to the N-terminus of the second monomer (Robinson and
Eckert, 1998). Since the C- and N-termini are the sites of
interaction with the annexin I target protein, it is very likely
that cross-links at this location would inactivate S100A11
interaction with annexin I––thereby terminating function.
Thus, transglutaminase-dependent cross-linking may act to
terminate S100A11 function.
S100A11 has also been shown to have an interesting
nuclear function. Sakaguchi et al showed the calcium-
dependent movement of S100A11 to the nucleus of normal
human keratinocytes and HaCaT cells (Sakaguchi et al,
2003). This movement involves S100A11 phosphorylation
and association with nucleolin, a nuclear protein that
shuttles between the cytoplasm and nucleus. S100A11
interaction with nucleolin in the nucleus results in the
displacement of Sp1 and Sp3 from a nucleolin-Sp1/3
complex. The increased level of non-complexed nuclear
Sp1/3 transcription factors is associated with increased
expression of the p21 gene. The increased expression of
p21, a cyclin-dependent kinase inhibitor, results in reduced
cell proliferation. Thus, as shown in Fig 2F, S100A11 also
has nuclear functions.
S100A12 and S100A15
S100A12 (calgranulin C, EN-RAGE) is a pro-inflammatory
protein that interacts with the receptor for advanced
glycation endproducts (RAGE). S100A12 is markedly over-
expressed in various inflammatory diseases (Yang et al,
2001; Rouleau et al, 2003; Foell et al, 2003a, b) including
psoriasis (Mirmohammadsadegh et al, 2000; Semprini et al,
2002). In involved psoriatic epidermis, S100A12 is ex-
pressed in the suprabasal epidermal layers (Mirmoham-
madsadegh et al, 2000; Semprini et al, 2002). S100A12 is
called EN-RAGE, as it is a RAGE receptor ligand (Hofmann
et al, 1999). RAGE is a member of the immunoglobulin
superfamily of cell surface proteins that interact with a
range of ligands, including advanced glycation endproducts
(AGE), amyloid fibrils, S100A12, and amphoterin. The
pathobiology observed in response to RAGE activation is
enhanced by accumulation of RAGE ligands at pathologic
sites, leading to further upregulation of the receptor and
sustained RAGE-dependent cell activation. This eventually
leads to cell dysfunction (Stern et al, 2002). It is not yet
known whether RAGE is activated in psoriasis; however,
this seems likely. Since RAGE functions as a progression
factor, driving cellular dysfunction and enhancing the host
response to tissue destruction, activation of RAGE by S100
proteins could contribute to an exacerbation of the psoriatic
phenotype.
S100A15 is a recently cloned S100 protein that is 93%
identical to S100A7 with lower levels of identify to S100A11
(34%) and S100A8 (29%) (Wolf et al, 2003). Compared with
normal epidermis, S100A15 mRNA levels are slightly
increased in non-lesional and markedly increased in lesional
psoriasis. Little is presently known regarding the function of
S100A15, but the close identity to S100A7 may suggest a
similar role.
Overall role for S100 proteins S100 proteins comprise a
family of homologous proteins that regulate a wide range of
cellular processes. Although precise functional roles have
not been assigned, our survey suggests some conclusions
regarding the role of S100 proteins in keratinocytes. A
common theme among S100 family members is an
involvement in inflammatory processes. It is perhaps not
surprising that the level of several S100 proteins, including
S100A2, S100A7, S100A8, and S100A9, and S100A15, are
markedly elevated in psoriasis. In this context, although it
has not been convincingly demonstrated, these proteins
may be exported from the cell and function as chemokines.
Although only a few studies have directly tested the
hypothesis that S100 proteins are key players in epidermal
inflammatory disease (Jinquan et al, 1996), a significant
body of circumstantial evidence suggests such a role. A
second common theme is that S100 proteins function in
membrane remodeling. They may play a role in the
remodeling that occurs during keratinocyte differentia-
tion—especially in reorganizing the keratinocyte surface. A
third possible function is suggested by the fact that some
S100 protein target proteins (e.g., annexins) function in the
formation of calcium channels. S100 proteins, in conjunc-
tion with annexins, may function to facilitate the transmem-
brane influx of calcium that occurs during terminal
differentiation. A fourth important observation that may
have functional consequences is that S100 proteins are
efficient transglutaminase substrates. This transglutami-
nase-dependent covalent protein modification results in
S100 protein incorporation into the cornified envelope.
Transglutaminase activity may also play a role in terminating
S100 protein interaction with target proteins. A fifth theme is
that intracellular movement is required for function. These
studies are mapping the intracellular distribution of indivi-
dual S100 proteins in keratinocytes and their movement in
response to exogenous agents. These studies are also
particularly important, since intracellular location can
profoundly influence function. In this context, S100 proteins
may move to locate their target proteins or they may
function to carry target proteins to new intra- and
extracellular locations. Finally, S100 proteins, covalently
cross-linked in the cornified envelope, may protect against
bacterial infection.
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